Advertisement

An Intervention Trial in High-Risk Asbestos-exposed Persons

  • Jerry W. McLarty
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 320)

Abstract

Lung cancer, the treatment of which is essentially no more effective today than it was 20 years ago, remains the major cause of cancer mortality in the United States, killing more than 140,000 persons annually. Persons who are occupationally exposed to asbestos are at extremely high risk for lung cancer, from 10 to 50 or more times higher than normal—depending upon their smoking history. In the following discussion, we present the study design for an ongoing intervention trial among 750 asbestos workers in Tyler, Texas. β-Carotene and retinol are being used as the chemopreventive agents and an intermediate end point, sputum atypia, as the measure of response. Some results of baseline data analysis (before initiation of treatment) will be presented below. Findings of toxicity, recruitment, and compliance will also be discussed.

Keywords

Serum Vitamin Lung Cancer Risk Asbestos Exposure Cervical Dysplasia Sputum Specimen 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rom WN, Travis WD, Brody AR. Cellular and molecular basis of the asbestos-related diseases. Am Rev Respir Dis 143:408–422,1991.PubMedGoogle Scholar
  2. 2.
    Jaurand MC. Particulate-state carcinogenesis: A survey of recent studies on the mechanisms of action of fibres. IARC Sci Publ 90:54–73, 1989.PubMedGoogle Scholar
  3. 3.
    Hurst GA, Spivey CG, Matlage WT, Miller JM, Faulk G, Hieger LR, McLarty JW, Greenberg SD. The Tyler Asbestos Workers Program: I. A medical surveillance model and method. Arch Environ Health 34:432–439, 1979.PubMedGoogle Scholar
  4. 4.
    Mayne ST. Beta-carotene and cancer prevention: What is the evidence? Conn Med 54:547–551,1990.PubMedGoogle Scholar
  5. 5.
    Hennekens CH. Micronutrients and cancer prevention (editorial). N Engl J Med 315:1288–1289, 1986.PubMedCrossRefGoogle Scholar
  6. 6.
    Hennekens CH. Vitamin A analogues in cancer chemoprevention. Important Adv Oncol 1986:23–35, 1986.Google Scholar
  7. 7.
    Fontham ETH. Protective dietary factors and lung cancer. Int J Epidemiol 19:S32–S42,1990.PubMedCrossRefGoogle Scholar
  8. 8.
    Sporn MB, Newton DL. Chemoprevention of cancer with retinoids. Federal Proceedings 38:2528–2534, 1979.Google Scholar
  9. 9.
    Bolag W, Matter A. From vitamin A to retinoids in experimental and clinical oncology: Achievements, failures and outlook. Ann N Y Acad Sci 359:9–21, 1981.CrossRefGoogle Scholar
  10. 10.
    Meyskens FL, Moon TE, Alberts DS, Bowden GT, Earnest DL. Vitamin A Program Project, ICRDB, Protocol No. POI CA 27502 (NCI Grant).Google Scholar
  11. 11.
    Alth G. Aspects of the immunologic treatment of lung cancer. Cancer Chemotherapy Reports 4:271–274,1973.Google Scholar
  12. 12.
    Peck GL, Olsen TG, Butkus D. Treatment of basal cell carcinomas with 13- cis -retinoic acid (abstract). Proceedings of the American Association for Cancer Research 20:56, 1979.Google Scholar
  13. 13.
    Muenter MD, Perry MO, Ludvig J. Chronic vitamin A intoxication in adults. Am J Med 50:129–136,1971.PubMedCrossRefGoogle Scholar
  14. 14.
    Bauernfeind JC. The Safe Use of Vitamin A: A Report of the International Vitamin A Consultative Group. Washington, DC: The Nutrition Foundation, 1980.Google Scholar
  15. 15.
    Bagdon RE, Zbinden G, Studer A. Chron ic toxicity studies of beta-carotene. Toxicol Appl Phannacol 2:225–236, 1960.CrossRefGoogle Scholar
  16. 16.
    Mathews-Roth M-M. Lack of genotoxicity with beta-carotene. Toxicol Lett 41:185–191,1988.PubMedCrossRefGoogle Scholar
  17. 17.
    Mathus VEM, Tytgat GN. Biological fate of the vitamin A transporting protein complex and beta-carotene after excessive dietary intake: Report of a case. Digestion 27:116–122,1983.CrossRefGoogle Scholar
  18. 18.
    Bendich A. The safety of beta-carotene. Nutr Cancer 11:207–214,1988.PubMedCrossRefGoogle Scholar
  19. 19.
    Atukorala S, Basu TK, Dickerson J WT. Vitamin A, zinc and lung cancer. Br J Cancer 40:927–931,1979.PubMedCrossRefGoogle Scholar
  20. 20.
    Wahi PN, Bodkhe RR, Arora S, Srivastava MC. Serum vitam in A studies in leukoplakia and carcinoma of the oral cavity. Indian J Pathol Bacteriol 5:10–16,1962.PubMedGoogle Scholar
  21. 21.
    Mettlin C, Graham S, Swanson M. Vitamin A and lung cancer. J Natl Cancer Inst 62:1435–1438,1979.PubMedGoogle Scholar
  22. 22.
    Menkes MS, Comstock GW, Vuilleumicr JP, Helsing KJ, Rider AA, Brookmeyer R. Serum beta-carotene, vitamins A and E; selenium, and the risk of lung cancer. N Engl J Med 315:1250–1254,1986.PubMedCrossRefGoogle Scholar
  23. 23.
    Shekelle RB, Lepper M, Liu S, Maliza C, Raynor WJJ, Rossof AH, Paul O, Shryock AM, Sunnier J. Dietary vitamin A and risk of cancer in the Western Electric study. Lancet 2:1186–1190,1981.Google Scholar
  24. 24.
    Kark JD, Smith AH, Switzer BR, Haunes CG. Serum vitamin A (retinol) and cancer incidence in Evans County, Georgia. J Nail Cancer Inst 66:7–16,1981.Google Scholar
  25. 25.
    Wald NJ, Thompson SG, Densem JW, Boreham J, Bailey A. Serum beta-carotene and subsequent risk of cancer: Results from the BUPA Study. Br J Cancer 57:428–433, 1988.PubMedCrossRefGoogle Scholar
  26. 26.
    Romney SL, Palan PR, Duttagupta C, Wassertheil-Smoller S, Wiley G, Slagle NS, Lucido D. Retinoids and the prevention of cervical dysplasias. Am J Obstet Gynecol 141:890–894, 1981.PubMedGoogle Scholar
  27. 27.
    Stich HF, Rosin MP, Homby AP, Mathew B, Sankaranarayanan R, Nair M K. Remission of oral leukoplakias and micronuclei in tobacco/betel quid chewers treated with bet -carotene and with beta-carotene plus vitamin A. Int J Cancer 42:195–199,1988.PubMedCrossRefGoogle Scholar
  28. 28.
    Yanagihara R, Holiday D, Riley L, O’Donnell L, Mabry L, Fagan M, McLarty J. Micronucleated sputum bronchial cells: Potential intermediate end point for lung cancer (abstract). Proceedings of the American Society of Clinical Oncology 8:58, 1989.Google Scholar
  29. 29.
    Santamaria L, Bianchi A, Amaboldi A, Ravetto C, Bianchi L, Pizzala R, Andreoni L, Santagati G, Bermond P. Chemoprevention of indirectand d ircctchem leaf care inogenesis by carotenoids as oxygen radical quenchers. Ann N Y Acad Sci 534:584–596, 1988.PubMedCrossRefGoogle Scholar
  30. 30.
    Mathews M, Roth M. Photoprotection by carotenoids. Federal Proceedings 46:1890–1893, 1987.Google Scholar
  31. 31.
    Abril ER, Rybski JA, Scuderi P, Watson RR. Beta-carotene stimulates human leukocytes to secrete a novel cytokine. J Leukoc Biol 45:255–261, 1989.PubMedGoogle Scholar
  32. 32.
    Bendich A. Antioxidant micronutrients and immune responses. Ann N Y Acad Sci 587:168–180, 1990.PubMedGoogle Scholar
  33. 33.
    Weitberg AB, Weitzman SA, Clark EP, Stossel TP. Effects of antioxidants on oxidant-induced sister chromatid exchange formation. J Clin Invest 75:1835–1841, 1985.PubMedCrossRefGoogle Scholar
  34. 34.
    Hazuka MB, Edwards PJ, Newman F, Kinzie JJ, Prasad KN. Beta-carotene indlices morphological differentiation and decreases adenylate cyclase activity in melanoma cells in culture. J Am Coll Nutr 9:143–149, 1990.PubMedGoogle Scholar
  35. 35.
    Melamed MR, Zaman MB, Flehinger BJ, Martini N. Radiologically occult in situ and incipient invasive epidermoid lung cancer. Am J Surg Pathol 1:5–16, 1977.PubMedCrossRefGoogle Scholar
  36. 36.
    Saccomanno G, Archer VE, Auerhack O, Saunders RP, Brennan LM. Development of carcinoma of the lung as reflected in exfoliated cells. Cancer 33:256–270, 1974.PubMedCrossRefGoogle Scholar
  37. 37.
    Yanagihara RH, McLarty J, Hieger LR, Hurst G, Greenberg SD, Mabry L, Farley M. The predictive value of sputum bronchial atypia in subjects at risk for lung cancer (abstract). Proceedings of the American Society of Clinical Oncology 6:166, 1987.Google Scholar
  38. 38.
    Whittemore AS, McLarty JW, Fortson N, Anderson K. Regression analysis of cytopathological data. Biometrics 38:899–905, 1982.PubMedCrossRefGoogle Scholar
  39. 39.
    McLarty JW, Yanagihara RH, Riley L. Characteristics of subjects with high and low serum beta-carotene: Implications for lung cancer risk (abstract). Proceedings of the American Society of Clinical Oncology 6:A897, 1987.Google Scholar
  40. 40.
    McLarty JW, Yanagihara RH, James HL, Riley L, Kummet TD, Smith K. Baseline data analysis of serum beta-carotene in a randomized clinical trial: The Tyler Cancer Prevention Program (abstract). Chest 91:301, 1987.Google Scholar
  41. 41.
    Ferris BG. Epidemiology Standardization Project, Part II. Am Rev Respir Dis 118:6, 1978.Google Scholar
  42. 42.
    Block G, Coyle L, Harvin A, Kessler L. A dietary and risk factor questionnaire and analysis system for personal computers. Am J Epidemiol 129:445–449, 1989.PubMedGoogle Scholar
  43. 43.
    Basu TK, Raven RW, Dickerson JWT, Williams DC. Vitamin A nutrition and its relationship with plasma cholesterol level in the patients with cancer. Int J Vitam Nutr Res 44:14–18, 1974.PubMedGoogle Scholar
  44. 44.
    Willet WC, Polk BF, Underwood BA, Meir MJ, Pressel S, Bosner B, Taylor O, Schneider EK, Hames C. Relation of serum vitamins A and E and carotenoids to the risk of cancer. N Engl J Med 310:430–434, 1984.CrossRefGoogle Scholar
  45. 45.
    Nierenberg DW, Stukel TA, Baron JA, Dain BJ, Greenberg ER. Determinants of plasma levels of beta-carotene and retinol: Skin Cancer Prevention Study Group. Am J Epidemiol 130:511–521, 1989.PubMedGoogle Scholar
  46. 46.
    Xu MJ, Peng YM, Liu Y, Alberts DS, Plezia PM, Sayers SW. Effect of chronic administration of beta-carotene on plasma alpha-tocopherol concentrations in normal subjects (abstract). Proceedings of the American Association for Cancer Research 31:126, 1990.Google Scholar

Copyright information

© Springer Science+Business Media New York 1992

Authors and Affiliations

  • Jerry W. McLarty
    • 1
  1. 1.Department of Epidemiology/BiomathematicsThe University of Texas Health Science Center at TylerTylerUSA

Personalised recommendations